The DOI matches its Crossref record; 62 of the 64 references it cites were found in a registry or an index.
Circular RNAs are long-lived and display only minimal early alterations in response to a growth factor
Open accessAbstract
Circular RNAs (circRNAs) are widespread circles of non-coding RNAs with largely unknown function. Because stimulation of mammary cells with the epidermal growth factor (EGF) leads to dynamic changes in the abundance of coding and non-coding RNA molecules, and culminates in the acquisition of a robust migratory phenotype, this cellular model might disclose functions of circRNAs. Here we show that circRNAs of EGF-stimulated mammary cells are stably expressed, while mRNAs and microRNAs change within minutes. In general, the circRNAs we detected are relatively long-lived and weakly expressed. Interestingly, they are almost ubiquitously co-expressed with the corresponding linear transcripts, and the respective, shared promoter regions are more active compared to genes producing linear isoforms with no detectable circRNAs. These findings imply that altered abundance of circRNAs, unlike changes in the levels of other RNAs, might not play critical roles in signaling cascades and downstream transcriptional networks that rapidly commit cells to specific outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“endogenous circRNAs lack the free ends necessary for exonuclease-mediated degradation, rendering them resistant to several mechanisms of RNA turnover and granting them extended lifespans as compared to their linear mRNA counterparts2, 9.”
From Engineering circular RNA for potent and stable translation in eukaryotic cells (2018) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast gapped-read alignment with Bowtie 2
Langmead, B., & Salzberg, S. L. (2012) · Nature Methods · doi:10.1038/nmeth.1923 · Cited by 56,400
MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068
Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y. C., Laslo, P., Cheng, J. X., Murre, C., Singh, H., & Glass, C. K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.004 · Cited by 13,382
Circular RNAs are a large class of animal RNAs with regulatory potency
Memczak, S., Jens, M., Elefsinioti, A., Torti, F., Krueger, J., Rybak, A., Maier, L., Mackowiak, S. D., Gregersen, L. H., Munschauer, M., et al. (2013) · Nature · doi:10.1038/nature11928 · Cited by 7,990
Natural RNA circles function as efficient microRNA sponges
Hansen, T. B., Jensen, T. I., Clausen, B. H., Bramsen, J. B., Finsen, B., Damgaard, C. K., & Kjems, J. (2013) · Nature · doi:10.1038/nature11993 · Cited by 7,985
Li, J.-H., Liu, S., Zhou, H., Qu, L.-H., & Yang, J.-H. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1248 · Cited by 4,686
Circular RNAs are abundant, conserved, and associated with ALU repeats
Jeck, W. R., Sorrentino, J. A., Wang, K., Slevin, M. K., Burd, C. E., Liu, J., Marzluff, W. F., & Sharpless, N. E. (2013) · RNA · doi:10.1261/rna.035667.112 · Cited by 4,388
The multilayered complexity of ceRNA crosstalk and competition
Tay, Y., Rinn, J., & Pandolfi, P. P. (2014) · Nature · doi:10.1038/nature12986 · Cited by 3,910
MicroRNA Targeting Specificity in Mammals: Determinants beyond Seed Pairing
Grimson, A., Farh, K. K.-H., Johnston, W. K., Garrett-Engele, P., Lim, L. P., & Bartel, D. P. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.06.017 · Cited by 3,766
circRNA biogenesis competes with pre-mRNA splicing
Ashwal-Fluss, R., Meyer, M., Pamudurti, N. R., Ivanov, A., Bartok, O., Hanan, M., Evantal, N., Memczak, S., Rajewsky, N., & Kadener, S. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.08.019 · Cited by 3,083
Cited by
Sorted by citations
Items 701–765 of 765
Iparraguirre, L., Alberro, A., Iñiguez, S. G., Muñoz‐Culla, M., Vergara, I., Matheu, A., & Otaegui, D. (2024) · Figshare · doi:10.6084/m9.figshare.26603506
Haque, S., Ames, R. M., Moore, K., Lee, B. P., Jeffery, N. M., & Harries, L. W. (2020) · Figshare · doi:10.6084/m9.figshare.12160500
Haque, S., Ames, R. M., Moore, K., Lee, B. P., Jeffery, N. M., & Harries, L. W. (2020) · Figshare · doi:10.6084/m9.figshare.12160488
Zhou, M., Yang, Z., 王丹波, Chen, P., & Zhang, Y. (2021) · Figshare · doi:10.6084/m9.figshare.13669308
Zhou, M., Yang, Z., 王丹波, Chen, P., & Zhang, Y. (2021) · Figshare · doi:10.6084/m9.figshare.13669314
Xia, Y., Lv, J., Jiang, T., Li, B., Li, Y., He, Z., Xuan, Z., Sun, G., Wang, S., Li, Z., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14234950
Xia, Y., Lv, J., Jiang, T., Li, B., Li, Y., He, Z., Xuan, Z., Sun, G., Wang, S., Li, Z., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14234959
Additional file 6 of The circular RNA circCPE regulates myoblast development by sponging miR-138
Ru, W., Qi, A., Shen, X., Yue, B., Zhang, X., Wang, J., Cao, H., & Chen, H. (2021) · Figshare · doi:10.6084/m9.figshare.16584680
Haque, S., Ames, R. M., Moore, K., Lee, B. P., Jeffery, N. M., & Harries, L. W. (2020) · Figshare · doi:10.6084/m9.figshare.12160521
Xia, Y., Lv, J., Jiang, T., Li, B., Li, Y., He, Z., Xuan, Z., Sun, G., Wang, S., Li, Z., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14234947
Haque, S., Ames, R. M., Moore, K., Lee, B. P., Jeffery, N. M., & Harries, L. W. (2020) · Figshare · doi:10.6084/m9.figshare.12160494
Feng, H., Deng, Z., Peng, W., Wei, X., Liu, J., & Wang, T. (2023) · Figshare · doi:10.6084/m9.figshare.22721347
Additional file 1 of CircRNAs and their regulatory roles in cancers
Tao, M., Zheng, M., Xu, Y., Ma, S., Zhang, W., & Ju, S. (2021) · Figshare · doi:10.6084/m9.figshare.16456929
Zhang, X., Wang, X., Lv, J., Huang, H., Wang, J., Zhuo, M., Tan, Z., Huang, G., Liu, J., Liu, Y., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23573600
Iparraguirre, L., Alberro, A., Iñiguez, S. G., Muñoz‐Culla, M., Vergara, I., Matheu, A., & Otaegui, D. (2024) · Figshare · doi:10.6084/m9.figshare.26603494
Zhou, M., Yang, Z., 王丹波, Chen, P., & Zhang, Y. (2021) · Figshare · doi:10.6084/m9.figshare.13669323
Iparraguirre, L., Alberro, A., Iñiguez, S. G., Muñoz‐Culla, M., Vergara, I., Matheu, A., & Otaegui, D. (2024) · Figshare · doi:10.6084/m9.figshare.26603497
Bersani, F., Picca, F., Morena, D., Righi, L., Napoli, F., Russo, M., Oddo, D., Rospo, G., Negrino, C., Castella, B., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22807458
Additional file 2 of The circular RNA circCPE regulates myoblast development by sponging miR-138
Ru, W., Qi, A., Shen, X., Yue, B., Zhang, X., Wang, J., Cao, H., & Chen, H. (2021) · Figshare · doi:10.6084/m9.figshare.16584668
Haque, S., Ames, R. M., Moore, K., Lee, B. P., Jeffery, N. M., & Harries, L. W. (2020) · Figshare · doi:10.6084/m9.figshare.12160527
Xia, Y., Lv, J., Jiang, T., Li, B., Li, Y., He, Z., Xuan, Z., Sun, G., Wang, S., Li, Z., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14234971
Ma, S., Kong, S., Gu, X., Xu, Y., Tao, M., Shen, L., Shen, X., & Ju, S. (2021) · Figshare · doi:10.6084/m9.figshare.13558308
Xia, Y., Lv, J., Jiang, T., Li, B., Li, Y., He, Z., Xuan, Z., Sun, G., Wang, S., Li, Z., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14234962
N 6-methyladenosine-modified circular RNAs in aging-associated gastrointestinal tumors
Duan, Z.-M., & Wu, G.-D. (2025) · Aging Research · doi:10.26599/agr.2025.9340057
Mechanistic roles of long non-coding RNAs in gastric cancer therapy resistance
Chen, J., & Gao, J. (2026) · Non-coding RNA Research · doi:10.1016/j.ncrna.2025.12.004
“…confers high resistance to degradation by RNA exonucleases, resulting in significantly greater intracellular stability compared to linear RNAs, this enables its persistent accumulation and longterm regulatory function, laying a structural foundation for its potential as a stable biomarker [32,33].”
The role of circular RNAs in the diagnosis and therapy of psoriasis
Li, J., & Liu, J. (2026) · Egyptian Journal of Dermatology and Venerology · doi:10.4103/ejdv.ejdv_68_25
Sun, B., Chen, B., Song, J., Zhang, W., & Yang, H. (2026) · Environmental and Experimental Botany · doi:10.1016/j.envexpbot.2026.106314
Li, H.-L., Xu, Y., Mo, J.-S., Zhao, X.-Y., Zhong, C.-L., Jia, Z.-W., Wang, X.-L., Zhao, B.-C., Chen, Y., Zheng, K., et al. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.114691
Zhu, L., He, C., Shi, H., Shao, G., & Sun, L. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.125.043108
mRNA therapeutics for inflammatory bone diseases: opportunity and challenge
Huang, Y., Huang, X.-H., Mao, H., & Zhang, L. (2026) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2026.126793
Possibilities of Circular RNA Interactions with Nucleic Acids and Proteins
Filippenkov, I. B., Mozgovoy, I. V., & Dergunova, L. V. (2025) · Molecular Genetics Microbiology and Virology · doi:10.3103/s0891416825700296
Jarroux, J. (2019) · theses.fr (ABES) · doi:10.70675/6004244ez8528z4704z9d6cz5dd43c9c2ba3
“Circular RNAs are an example of highly stable lncRNAs compared to their linear counterparts (Enuka et al., 2016).”
Non-coding RNAs as prognostic biomarkers of cardiac arrest
Stefanizzi, F. M. (2022) · theses.fr (ABES) · doi:10.70675/2570d853z52e6z4dc1z86cez487c8f70b6dd
Li, Y., Guo, Z., Zhao, P., Dong, Y., Mei, Y., Li, Q., Kong, L., & Wang, Z. (2026) · Advanced Healthcare Materials · doi:10.1002/adhm.202505504
“In contrast, circular RNAs exhibit exceptionally long intracellular half‑lives owing to their covalently closed circular structure, which confers resistance to nuclease‑mediated degradation [35].”
Down-regulation of circ0001361 induces apoptosis and suppresses the progression of glioma
Zou, X., Wang, P., 农蔚霞, Liu, C., Li, F., Xue, C., Li, X., Wang, Y., Ge, Y., Zhang, Q., et al. (2026) · PLoS ONE · doi:10.1371/journal.pone.0343681
“Due to the closed circular structure of circRNA molecules, they are not affected by RNA exonuclease and are not easily degraded [21], which have longer half-life than linear RNAs [22,23].”
Puri, S., van der Spek, S. J. F., Lin, M., Wang, Z., Porter, J., Hu, J., Hu, L., Rondón-Ortiz, A. N., Knyshov, A., Libera, J., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71436
“6,7 17 Advances in bioinformatics and high-throughput sequencing techniques have enabled the discovery and analysis of circRNAs, further establishing their significance in cellular homeostasis and disease pathogenesis. circRNAs have emerged as key players in neurodegeneration, providing insights…”
Molecular arms races at the virus-host splicing interface and their pathogenic implications
Chen, Y., Pan, W., Miao, X., Liu, J., & Jiang, Z. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1819878
“Recent evidence demonstrates that circRNAs are not only abundant and evolutionarily conserved but also exhibit exceptional biological stability due to their inherent resistance to exonuclease-mediated degradation (Enuka et al., 2016; Fontemaggi et al., 2021; Yu et al., 2023).”
A novel circular RNA biomarker signature to facilitate an improved diagnosis of pleural mesotheliomaPreprint
Johnson, B., Rath, E., Baker, D., Zelei, R., Zhuang, L., Shi, H., Fisher, S. A., Winata, P., Lin, R., Kovačević, Ž., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-9625420/v1
A Divergent TaqMan RT-qPCR Strategy for Isoform-Resolved Detection of HIV-1 Circular RNAs
Mauer, C., Paz, S., & Caputi, M. (2026) · Methods and Protocols · doi:10.3390/mps9030077
“Because circRNAs lack free 5 ′ and 3 ′ ends, they are resistant to exonucleases that degrade linear RNAs; a property that contributes to their stability and which has made them attractive candidates for biomarkers and therapeutic targets [2].”
Non-coding RNAs: Therapeutic Implications in Cancers
Alves, R., Jorge, J., Costa, M. I., Lapa, B., Sarmento‐Ribeiro, A. B., & Gonçalves, A. C. (2026) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-032-24071-2_10
Dogra, A., Mani, S., & Hasija, Y. (2026) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770.2026.2677626
Rajendran, R. L., Mahajan, A. A., ArulJothi, K. N., Rajendran, S. N. S., Gangadaran, P., & Ahn, B. (2026) · World Journal of Stem Cells · doi:10.4252/wjsc.120369
Circular RNA aptamers as superb sub-stoichiometric chaperones of TDP-43 condensationPreprint
Wu, H. B., Luan, P.-F., Hu, J., Nan, F., Li, L., Pan, Y.-Y., Jiang, B.-W., Chen, J., Liu, Y.-X., Wei, Y., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.01.729436
Circular RNA serves as an upstream regulator of the miRNA//ABCC1 axis in human cancers
Zou, Q., & Yang, X. (2026) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2026.109054
The bench-to-bedside journey of circular RNAs in cancer: Status, challenges and future prospects
Lin, H., Tu, Y., Wang, P., Wang, T., & Long, F. (2026) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2026.189639
Xiao, Y., He, Z., Al-subari, M. H., Zhang, H., Wu, X., Song, Z., & Zhu, Q. (2026) · Oncogene · doi:10.1038/s41388-026-03869-8
“The remarkable stability of circRNAs, conferred by their resistance to RNase resulting from the lack of 5 ’ caps and 3 ’ poly(A) tails, along with their ability to accumulate stably in exosomes [7], underscores their exceptional potential as reliable biomarkers and therapeutic targets [8 – 10].”
Cardiac regeneration and repair: the emerging mechanisms and therapeutic approaches
Li, Y., Zheng, K., Liu, Y., Li, R., Wang, S., Ye, W., Luo, Z., Li, X., Tao, Z., Xia, J., et al. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00504-6
Circular Photocaged mRNA for Light‐induced Late‐stage Activation of Translation
Terzi, B., Dahm, G. C., Kg, H., Sumser, M., Kimura, Y., Abe, H., & Rentmeister, A. (2026) · Angewandte Chemie International Edition · doi:10.1002/anie.8731921
“Parts of this figure were created using biorender.com. back-splicing and were shown to have higher stability [16].”
Terzi, B., Dahm, G. C., Kg, H., Sumser, M., Kimura, Y., Abe, H., & Rentmeister, A. (2026) · Angewandte Chemie · doi:10.1002/ange.8731921
Circular RNA Translation Modulation via Small Ligand-Mediated Protein Stabilization
Li, H., Xin, K., Tang, L., Wang, F., & Jiang, J. (2026) · Analytical Chemistry · doi:10.1021/acs.analchem.6c03443
When circular RNAs meet the genome: CiR-loops as chromatin regulators and disease drivers
Zhou, M., You, J., Chen, L., Su, R., & Huang, C. (2026) · Nucleic Acids Research · doi:10.1093/nar/gkag816
“However, it is important to note that the circular structure of circRNAs renders them resistant to degradation by exoribonucleases and thus confers exceptional stability with half-lives exceeding 24 h [ 27–29 ].”
Xue, P., Gao, Y., Li, T., Gao, J., Chen, J., Liu, W., Jin, F., & Guo, X. (2026) · Experimental Cell Research · doi:10.1016/j.yexcr.2026.115157
Emerging strategies and innovations in circular RNA synthesis
Bansode, N. D., Phutane, K. M., Latthe, P. R., Bandapalli, O. R., Babu-Karunakaran, G., & Mohanty, S. K. (2026) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2026.103067
“89,110,149,167 Adopting disulfide-mediated circularization introduces a redox-sensitive (–”
Wang, S., Qu, Y., Liu, W., Qiu, X., Tan, L., Song, C., Liao, Y., Chen, L., Ding, C., & Ren, T. (2026) · Journal of Virology · doi:10.1128/jvi.01121-26
The emerging roles of noncoding RNAs in cancer
Samuel, A., & Călin, G. A. (2026) · Carcinogenesis · doi:10.1093/carcin/bgag053
Circular RNAs and SIRT1 in post-transcriptional regulation and human disease
Vakili, O., Yousefi, Z., Igder, S., Yarahmadi, S., Gheibi, M., Taghizadeh, M., Moshtaghian, M. S., Sartavi, F., Yahyazadeh, S., Shafiee, S. M., et al. (2026) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2026.168451
Next-generation CAR therapies enabled by mRNA engineering and delivery
Zhao, Q., Wen, Q., Pu, P., Xu, C., Hu, Q., Zhou, Z., Hua, X., & Zhang, X. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.09.001
Enhanced CRISPR-Cas3-mediated genome editing using circularized crRNAs
Mikamo, K., Yoshimi, K., Abe, H., Takeshita, K., Abe, H., & Mashimo, T. (2026) · iScience · doi:10.1016/j.isci.2026.117481
“25,26 Indeed, our ccrRNA design demonstrated improved intracellular stability, with approximately 2-fold higher retention compared with that for pre-crRNAs at 24 h post-transfection (Figures 1D and 5B).”
Circular RNAs as central regulators of RNA stability
Boo, S. H., Kang, E., Kang, D., & Kim, Y. K. (2026) · Trends in Genetics · doi:10.1016/j.tig.2026.08.003
A circular RNA modulates IL-6 transcription via HuR-dependent stabilization of C/EBPβ mRNA
Hiroki, S., Ori, D., Agari, K., Kano, N., & Kawai, T. (2026) · The Journal of Immunology · doi:10.1093/jimmun/vkag251
Walsh, K. E., & Wang, R. C. (2026) · JID Innovations · doi:10.1016/j.xjidi.2026.100547
Hushmandi, K., Mirnejad, A. M., Bemidinezhad, A., Nejati, H., Ghaderi, M., Razavi, F. T., Pardis, D., Mafi, A., Alimohammadi, M., & Farahani, N. (2026) · Clinical & Translational Oncology · doi:10.1007/s12094-026-04577-1
11- Circular RNAs in Carcinogenesis
Al-Janabi, I. I. (2026) · Jordan Journal of Pharmaceutical Sciences · doi:10.35516/jjps.v19i3.3988
Cook, A., Yadav, P. K., Helmy, E. W., Vlasova, K. Y., Chang, H. Y., & Wender, P. A. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.6c14175
Metadata
- Authors
- Enuka, Y., Lauriola, M., Feldman, M. E., Sas-Chen, A., Ulitsky, I., & Yarden, Y.
- Affiliations
- Weizmann Institute of Science (IL)
- Corresponding author
- Yarden, Yosef
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-12-10
- Volume
- 44
- Issue
- 3
- Pages
- 1370-1383
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- PMC
- PMC4756822
- OpenAlex
- W2285247593
- Cited by
- 757
- References
- 64
- Citations by year
- 2026: 66 · 2025: 91 · 2024: 100 · 2023: 105 · 2022: 93 · 2021: 107 · 2020: 68 · 2019: 57 · 2018: 33 · 2017: 26 · 2016: 9
- FWCI
- 9.85
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nucleic Acids Research (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion, cc-by-nc)
- HighWire Press Open Archive (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Circular RNAs in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Keywords
- circular RNA, epidermal growth factor, mammary epithelial cells, RNA stability, non-coding RNA, microRNA, cell migration, growth factor signaling
- MeSH terms
- RNA, Circular, Breast, Cell Line, Epidermal Growth Factor, Epithelial Cells, Humans, RNA, RNA, Messenger, Gene Expression, Transforming Growth Factor alpha, Reverse Transcriptase Polymerase Chain Reaction, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, RNA Stability, MicroRNAs, Heparin-binding EGF-like Growth Factor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review